ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2123

Dose Trabecular Bone Score (TBS) Add Predictive Value to Fracture Risk Assessment (FRAX) in Rheumatoid Arthritis?

Jia-Feng Chen1, Tien-Tsai Cheng2 and Hong-Yo Kang3, 1Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, 2Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung, Taiwan, 3Graduate Institute of Clinical Medical Sciences, Chang Gung University, College of Medicine, Kaohsiung, Taiwan

Meeting: ACR Convergence 2023

Keywords: Bone density, Clinical Osteoporosis, Fracture, osteoporosis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Trabecular bone score (TBS) of lumbar spine is a dual X-ray densitometry (DXA)-based tool to evaluate bone microarchitecture, providing information on bone quality in metabolic bone diseases. The aim of this study is to assess whether TBS provides additional benefit to Fracture Risk Assessment (FRAX) tool to predict fractures in rheumatoid arthritis (RA) patients.

Methods: This is a retrospective study enrolling RA patients who fulfilled ACR/EULAR 2010 criteria from September 2014 to April 2021. We recruited participants aged between 40-90 and excluded those with malignancy. At enrollment, we measured bone mineral density (BMD) by Dual X-ray densitometry (DXA) at hip and lumbar spine, and assessed TBS at the lumbar spine. The 10-year risk of major osteoporotic fractures and TBS-adjusted risks were calculated on the FRAX website (https://frax.shef.ac.uk/tbs/index.aspx), and the FRAX scores were adjusted by glucocorticoid dose. In current studies, three FRAX models were evaluated, including conventional FRAX score, FRAX adjusted by TBS (TBS-FRAX) and FRAX without input of BMD (FRAX-noBMD). All patients were followed for at least three years to monitor fractures. We defined prevalent vertebral fracture by the morphometric change of vertebral bodies on the X-rays at baselines, according to Genant’s semiquantitative assessment. New fracture was defined by any clinical fragility fractures by medical records or vertebral body morphometrical changes after comparing baseline and final X-ray images by independent radiologists. Receiver operating characteristic (ROC) curves were illustrated to compare prediction models.

Results: Fifty-three RA participants were enrolled in current study, with a mean age of 55.8± 9.6 years and female predominant (83.0%). Among them, 14 (26.4%) had prevalent vertebral fractures at baseline, while 11 (20.8%) developed new fractures during follow-up. For prevalent vertebral fracture, the area under ROC curves (AUCs) of TBS-FRAX, FRAX, FRAX-noBMD were 0.874, 0.842, and 0.881(all p-value < 0.001), respectively, and there was no statistical significance between different models (Image 1). Regarding new fracture, the AUCs were 0.662, 0.626, and 0.633, and the p-values were 0.052, 0.114, and 0.127, respectively. Also, no statistical significance was displayed between models (Image 2).

Conclusion: FRAX alone demonstrates good prediction ability for prevalent vertebral fractures, so TBS-adjusted FRAX does not add much value to the outcome. The performance of test models is not optimal for new fractures, and adding TBS might improve prediction ability with a borderline of statistical significance.

Supporting image 1

Comparison between ROC curves: TBS-FRAX vs. FRAX, p=0.42; TBS-FRAX vs. FRAX-no BMD, p=0.86; FRAX vs. FRAX-no BMD, p=0.24. Abbreviations: Receiver operating characteristic (ROC); Fracture Risk Assessment (FRAX); Trabecular bone score (TBS); bone mineral density (BMD).

Supporting image 2

Comparison between ROC curves: TBS-FRAX vs. FRAX, p=0.26; TBS-FRAX vs. FRAX-no BMD, p=0.64; FRAX vs. FRAX-no BMD, p=0.88. Abbreviations: Receiver operating characteristic (ROC); Fracture Risk Assessment (FRAX); Trabecular bone score (TBS); bone mineral density (BMD).


Disclosures: J. Chen: None; T. Cheng: None; H. Kang: None.

To cite this abstract in AMA style:

Chen J, Cheng T, Kang H. Dose Trabecular Bone Score (TBS) Add Predictive Value to Fracture Risk Assessment (FRAX) in Rheumatoid Arthritis? [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/dose-trabecular-bone-score-tbs-add-predictive-value-to-fracture-risk-assessment-frax-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dose-trabecular-bone-score-tbs-add-predictive-value-to-fracture-risk-assessment-frax-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology